Pamela Gavin: 1 in 10 Americans Live With A Rare Disease – That Is Not Rare, That Is Public Health
Pamela Gavin, Chief Executive Officer at National Organization for Rare Disorders (NORD), shared on LinkedIn:
”Today is Rare Disease Day.
1 in 10 Americans live with a rare disease.
That is not rare.
That is public health.
This year’s theme, ‘More Than You Can Imagine’, reflects the reality millions of families face: delayed diagnoses, limited treatments, fragile access.
- Rare disease is more complex than many realize.
- More costly.
- More interconnected than our systems are built to manage.
It is also more solvable than we are currently delivering.
Breakthrough science is accelerating.
Families should not have to wait for systems to catch up.
Progress depends on sustained NIH investment.
- A strong, fully staffed FDA.
- Policies that reward responsible innovation.
- Manufacturing that can scale.
- Coverage that ensures access.
A therapy approved is not a therapy accessed.
Rare disease is not niche. It is a national and global health priority hiding in plain sight and meeting this moment requires coordinated leadership across sectors.
For 17 years, NORD has served as the official U.S. sponsor of Rare Disease Day, in partnership with EURORDIS-Rare Diseases Europe and its alliance partners worldwide.
That role is both a privilege and a responsibility.
Today, we celebrate this community whose persistence has reshaped what is possible.
And we recommit to building the infrastructure, partnerships, and policy environment that turn breakthroughs into access and momentum into lasting progress.
More than you can imagine.
But not more than we can solve if we choose to build a system worthy of the community it serves.”

Stay updated with Hemostasis Today.
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question
-
Oct 20, 2026, 04:04Sadia Kamal: Honored to Receive the Outstanding Abstract Award at the 20th Midwest Platelet Conference
-
Oct 20, 2026, 04:03Yu-Hsuan Chen: One Antibody, Two Diseases from FcRn Biology to Clinical Translation
-
Oct 20, 2026, 03:49Domenico Simone Castiello: Rethinking Prolonged DAPT in Multivessel PCI – Insights from the DAPT-MVD Trial
-
Oct 20, 2026, 03:37Rucha Patil: Scaling POC Diagnostics for Haemophilia A and VWD Across India
-
Oct 20, 2026, 03:31Zena Vexler: Targeting Neutrophil Elastase and NETosis to Mitigate Infection-Triggered Childhood Stroke
-
Oct 20, 2026, 03:24Chaza Alaji: Diagnosing Protein C and Protein S Deficiency
-
Oct 20, 2026, 03:24Mou Nandi: How Maternal Health During Pregnancy May Shape Infant Development
-
Oct 20, 2026, 03:13Sumyea Kabir: Pre-Analytical Quality in Phlebotomy – Preventing In Vitro Hemolysis